Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionDual inhibitor of IL-17A and tumor necrosis factor (TNF)
Molecular Target Interleukin-17A (IL-17A) ; Tumor necrosis factor (TNF)
Mechanism of ActionTumor necrosis factor (TNF) alpha inhibitor; Interleukin-17 (IL-17) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today